Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jacob J. Adashek"'
Autor:
Hanna E. Persha, Shumei Kato, Pradip De, Jacob J. Adashek, Jason K. Sicklick, Vivek Subbiah, Razelle Kurzrock
Publikováno v:
Journal of Hematology & Oncology. 15
There is a paucity of information about molecularly driven therapy in osteosarcomas. We report a 31-year-old woman with chemotherapy–refractory metastatic osteosarcoma who was successfully treated with the combination of palbociclib (CDK4/6 inhibit
Publikováno v:
Cureus
Lynch syndrome is the most common form of hereditary colorectal cancer and is associated with an increased incidence of endometrial cancer, small bowel cancer, and other malignancies. The advent of immune checkpoint blockade, next-generation sequenci
Publikováno v:
Cureus
Primary cutaneous gamma delta T-cell lymphoma (PCGD-TCL) is a rare lymphoma that makes up less than 1% of all cutaneous T-cell lymphomas. Patients with PCGD-TCL typically present with rapidly progressing plaques and ulceronecrotic nodules most freque
Autor:
Young-Chul Kim, Jad Chahoud, Jacob J. Adashek, S. Shah, P.E. Spiess, Nadya Mason, B.J. Manley
Publikováno v:
Annals of Oncology. 32:S692
Autor:
Jacob J. Adashek, Suzanna Lee, Shumei Kato, Razelle Kurzrock, Ryosuke Okamura, S. Gumas, Jason K. Sicklick
Publikováno v:
Annals of Oncology. 31:S275-S276
Publikováno v:
Annals of Oncology. 30:v504-v505
Background The use of immunotherapy in multiple cancer types is becoming mainstay along with next-generation sequencing (NGS) to identify potential actionable targets. We hypothesized that some immunoregulatory molecules are often found upregulated w
Autor:
Uri M. Ben-Zur, Menachem Nagar, Richard J. Pietras, Jonathan M Yaghoubian, Jacob J. Adashek, Bahareh Yaghoubian-Yazi, Nojan Toomari
Publikováno v:
Case Reports in Cardiology, Vol 2017 (2017)
Case Reports in Cardiology
Case Reports in Cardiology
We present the case of a patient with a deep vein thrombosis (DVT) who failed rivaroxaban therapy. Our patient initially presented with left lower extremity edema, erythema, and pain. He was subsequently started on rivaroxaban therapy for a combined
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e5ef09950cf6b0493cafe7c80d474e6
https://escholarship.org/uc/item/3n85d7df
https://escholarship.org/uc/item/3n85d7df
Autor:
Cristiane Decat Bergerot, Nazli Dizman, Paulo Gustavo Bergerot, Errol J. Philip, Sumanta K. Pal, Meghan Salgia, JoAnn Hsu, Jacob J. Adashek
Publikováno v:
Annals of Oncology. 29:viii318